MedTrace Logo

Vaginal Microbiome and HPV Pre-malignant and Cervical Dysplasia

NCT05640700 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2025-03-19

No results posted yet for this study

Summary

In this study, the investigators will prospectively collect, analyze and integrate information regarding vaginal microbiome composition and HPV presence in women with cervical pathologies (high-grade CIN and CC) and controls, to construct a large dataset from patients with pre-cancerous cervical lesions and healthy women, to evaluate the personalized contribution of the vaginal microbiome to the CIN-CC sequence.

Conditions

Sponsors & Collaborators

  • Hadassah Medical Organization

    lead OTHER

Principal Investigators

  • Ahinoam Lev Sagie, MD · Hadassah Medical Organization

Eligibility

Min Age
25 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-09
Primary Completion
2025-12-30
Completion
2025-12-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05640700 on ClinicalTrials.gov